CD44 and neoplasm: After >10 passages, the majority of the PPT2 cells expressed cell surface markers commonly used for the isolation of tumor-initiating cells from different types of human cancer, including CD133, CD44, CD44v6, EpCAM, CD166, CD49f, and presently, they retain these features after more than 26 passages.